Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Skull Base Neoplasms 1Patients Who Are Treated With Tyrosine Kinase Inhibitors 1Anosmia 1

Interventions

Cisplatin 3202Cyclophosphamide 3195Carboplatin 2977Radiotherapy 2790Paclitaxel 2718Gemcitabine 2572pembrolizumab 2385Bevacizumab 2209Docetaxel 2199Fluorouracil 1851Capecitabine 1833Oxaliplatin 1742Dexamethasone 1605Nivolumab 1581Doxorubicin 1501Rituximab 1488Magnetic Resonance Spectroscopy 1387Etoposide 1346Irinotecan 1248Leucovorin 1226Drug Therapy 1205Cytarabine 1130Pemetrexed 1076fludarabine 1063Specimen Handling 1017Vincristine 964Cetuximab 945Trastuzumab 945Prednisone 942Lenalidomide 937

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Olfactory Training × Clear all
NCT05912881 2026-02-18

Chemosensory Dysfunction and Recovery in Endoscopic Endonasal Skull Base Surgery

Johns Hopkins University

Phase NA Completed
41 enrolled

Anosmia, Skull Base Neoplasms

NCT07258589 2025-12-02

TASTY-training

University Medical Center Groningen

Phase NA Recruiting
90 enrolled

Patients Who Are Treated With Tyrosine Kinase Inhibitors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡